{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T13:34:40Z","timestamp":1791812080340,"version":"4.3.4"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,5,22]],"date-time":"2021-05-22T00:00:00Z","timestamp":1621641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,22]],"date-time":"2021-05-22T00:00:00Z","timestamp":1621641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"French Ministry of Health","award":["PHRC-I n\u00b0 13-077"],"award-info":[{"award-number":["PHRC-I n\u00b0 13-077"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Arch Occup Environ Health"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s00420-021-01706-x","type":"journal-article","created":{"date-parts":[[2021,5,22]],"date-time":"2021-05-22T11:02:31Z","timestamp":1621681351000},"page":"1839-1850","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Nurses\u2019 internal contamination by antineoplastic drugs in hospital centers: a cross-sectional descriptive study"],"prefix":"10.1007","volume":"94","author":[{"given":"Antoine","family":"Villa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Molimard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dunia","family":"Sakr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9gis","family":"Lassalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Bignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrice","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali","family":"Rouyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Mathoulin-Pelissier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Baldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Verdun-Esquer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireille","family":"Canal-Raffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,22]]},"reference":[{"key":"1706_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/10937404.2013.864250","volume":"17","author":"LL Aylward","year":"2014","unstructured":"Aylward LL, Hays SM, Smolders R et al (2014) Sources of variability in biomarker concentrations. J Toxicol Environ Health B Crit Rev 17:45\u201361. https:\/\/doi.org\/10.1080\/10937404.2013.864250","journal-title":"J Toxicol Environ Health B Crit Rev"},{"key":"1706_CR2","first-page":"1458","volume":"17","author":"S Baniasadi","year":"2018","unstructured":"Baniasadi S, Alehashem M, Yunesian M, Rastkari N (2018) Biological monitoring of healthcare workers exposed to antineoplastic drugs: urinary assessment of cyclophosphamide and ifosfamide. Iran J Pharm Res 17:1458\u20131464","journal-title":"Iran J Pharm Res"},{"key":"1706_CR3","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1289\/ehp.7337","volume":"113","author":"DB Barr","year":"2005","unstructured":"Barr DB, Wilder LC, Caudill SP et al (2005) Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ Health Perspect 113:192\u2013200. https:\/\/doi.org\/10.1289\/ehp.7337","journal-title":"Environ Health Perspect"},{"key":"1706_CR4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/BF00378081","volume":"50","author":"A Berlin","year":"1982","unstructured":"Berlin A, Yodaiken RE, Logan DC (1982) International seminar on the assessment of toxic agents at the workplace roles of ambient and biological monitoring, Luxembourg, 8\u201312 December, 1980. Summary report. Int Arch Occup Environ Health 50:197\u2013207. https:\/\/doi.org\/10.1007\/BF00378081","journal-title":"Int Arch Occup Environ Health"},{"key":"1706_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2016.10.021","author":"M Canal-Raffin","year":"2016","unstructured":"Canal-Raffin M, Khennoufa K, Martinez B et al (2016) Highly sensitive LC-MS\/MS methods for urinary biological monitoring of occupational exposure to cyclophosphamide, ifosfamide, and methotrexate antineoplastic drugs and routine application. J Chromatogr B Analyt Technol Biomed Life Sci. https:\/\/doi.org\/10.1016\/j.jchromb.2016.10.021","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"1706_CR6","first-page":"207","volume":"30","author":"AL Chasson","year":"1960","unstructured":"Chasson AL, Grady HJ, Stanley MA (1960) Determination of creatinine by means of automatic chemical analysis. Tech Bull Regist Med Technol 30:207\u2013212","journal-title":"Tech Bull Regist Med Technol"},{"key":"1706_CR7","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3322\/canjclin.56.6.354","volume":"56","author":"TH Connor","year":"2006","unstructured":"Connor TH, McDiarmid MA (2006) Preventing occupational exposures to antineoplastic drugs in health care settings. CA Cancer J Clin 56:354\u2013365. https:\/\/doi.org\/10.3322\/canjclin.56.6.354","journal-title":"CA Cancer J Clin"},{"key":"1706_CR8","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1097\/JOM.0000000000000249","volume":"56","author":"TH Connor","year":"2014","unstructured":"Connor TH, Lawson CC, Polovich M, McDiarmid MA (2014) Reproductive health risks associated with occupational exposures to antineoplastic drugs in health care settings: a review of the evidence. J Occup Environ Med 56:901\u2013910. https:\/\/doi.org\/10.1097\/JOM.0000000000000249","journal-title":"J Occup Environ Med"},{"key":"1706_CR9","doi-asserted-by":"publisher","first-page":"4110","DOI":"10.1039\/c8an00479j","volume":"143","author":"A Dhersin","year":"2018","unstructured":"Dhersin A, Atg\u00e9 B, Martinez B et al (2018) Biomonitoring of occupational exposure to 5-FU by assaying \u03b1-fluoro-\u03b2-alanine in urine with a highly sensitive UHPLC-MS\/MS method. Analyst 143:4110\u20134117. https:\/\/doi.org\/10.1039\/c8an00479j","journal-title":"Analyst"},{"key":"1706_CR10","doi-asserted-by":"publisher","first-page":"589","DOI":"10.13075\/mp.5893.00724","volume":"69","author":"S Dugheri","year":"2018","unstructured":"Dugheri S, Bonari A, Pompilio I et al (2018) Analytical strategies for assessing occupational exposure to antineoplastic drugs in healthcare workplaces. Med Pr 69:589\u2013604. https:\/\/doi.org\/10.13075\/mp.5893.00724","journal-title":"Med Pr"},{"key":"1706_CR11","volume-title":"Guideline on bioanalytical method validation","author":"EMEA","year":"2011","unstructured":"EMEA (2011) Guideline on bioanalytical method validation. European Medicines Agency, Amsterdam"},{"key":"1706_CR12","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/BF00380766","volume":"58","author":"CT Evelo","year":"1986","unstructured":"Evelo CT, Bos RP, Peters JG, Henderson PT (1986) Urinary cyclophosphamide assay as a method for biological monitoring of occupational exposure to cyclophosphamide. Int Arch Occup Environ Health 58:151\u2013155. https:\/\/doi.org\/10.1007\/BF00380766","journal-title":"Int Arch Occup Environ Health"},{"key":"1706_CR13","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00420-004-0595-1","volume":"78","author":"W Fransman","year":"2005","unstructured":"Fransman W, Vermeulen R, Kromhout H (2005) Dermal exposure to cyclophosphamide in hospitals during preparation, nursing and cleaning activities. Int Arch Occup Environ Health 78:403\u2013412. https:\/\/doi.org\/10.1007\/s00420-004-0595-1","journal-title":"Int Arch Occup Environ Health"},{"key":"1706_CR14","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1093\/annhyg\/mel081","volume":"51","author":"W Fransman","year":"2007","unstructured":"Fransman W, Peelen S, Hilhorst S et al (2007) A pooled analysis to study trends in exposure to antineoplastic drugs among nurses. Ann Occup Hyg 51:231\u2013239. https:\/\/doi.org\/10.1093\/annhyg\/mel081","journal-title":"Ann Occup Hyg"},{"key":"1706_CR15","unstructured":"GLOBOCAN (2020) Cancer today. https:\/\/gco.iarc.fr\/. Accessed 15 Nov 2020"},{"key":"1706_CR16","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s00420-007-0284-y","volume":"81","author":"M Hedmer","year":"2008","unstructured":"Hedmer M, Tinnerberg H, Axmon A, J\u00f6nsson BAG (2008) Environmental and biological monitoring of antineoplastic drugs in four workplaces in a Swedish hospital. Int Arch Occup Environ Health 81:899\u2013911. https:\/\/doi.org\/10.1007\/s00420-007-0284-y","journal-title":"Int Arch Occup Environ Health"},{"key":"1706_CR17","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/s0140-6736(84)92111-1","volume":"1","author":"M Hirst","year":"1984","unstructured":"Hirst M, Tse S, Mills DG et al (1984) Occupational exposure to cyclophosphamide. Lancet 1:186\u2013188. https:\/\/doi.org\/10.1016\/s0140-6736(84)92111-1","journal-title":"Lancet"},{"key":"1706_CR18","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.shaw.2014.06.001","volume":"5","author":"C-Y Hon","year":"2014","unstructured":"Hon C-Y, Barzan C, Astrakianakis G (2014) Identification of knowledge gaps regarding healthcare workers\u2019 exposure to antineoplastic drugs: review of literature, North America versus Europe. Saf Health Work 5:169\u2013174. https:\/\/doi.org\/10.1016\/j.shaw.2014.06.001","journal-title":"Saf Health Work"},{"key":"1706_CR19","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s00420-015-1026-1","volume":"88","author":"C-Y Hon","year":"2015","unstructured":"Hon C-Y, Teschke K, Shen H et al (2015) Antineoplastic drug contamination in the urine of Canadian healthcare workers. Int Arch Occup Environ Health 88:933\u2013941. https:\/\/doi.org\/10.1007\/s00420-015-1026-1","journal-title":"Int Arch Occup Environ Health"},{"key":"1706_CR20","volume-title":"Some antineoplastic and immunosuppressive agents","author":"IARC","year":"1981","unstructured":"IARC (1981) Some antineoplastic and immunosuppressive agents. IARC, Lyon"},{"key":"1706_CR21","volume-title":"Overall evaluations of carcinogenicity: an updating of IARC monographs volumes 1\u201342, IARC","author":"IARC","year":"1987","unstructured":"IARC (1987) Overall evaluations of carcinogenicity: an updating of IARC monographs volumes 1\u201342. IARC, Lyon"},{"key":"1706_CR22","volume-title":"Some antiviral and antineoplastic drugs, and other pharmaceutical agents","author":"IARC","year":"2000","unstructured":"IARC (2000) Some antiviral and antineoplastic drugs, and other pharmaceutical agents. IARC, Lyon"},{"key":"1706_CR23","unstructured":"IARC (2012) Pharmaceuticals. IARC, Lyon"},{"key":"1706_CR26","volume-title":"INRS\u2014administration. Travailler en s\u00e9curit\u00e9 avec les m\u00e9dicaments cytotoxiques","author":"INRS","year":"2018","unstructured":"INRS (2018a)\u00a0[Administration. Working safely with cytotoxic drugs]. INRS, Paris. https:\/\/www.inrs.fr\/. Accessed 15 Nov 2020"},{"key":"1706_CR25","volume-title":"INRS\u2014Soins au patient et entretien de la chamber. Travailler en s\u00e9curit\u00e9 avec les m\u00e9dicaments cytotoxiques","author":"INRS","year":"2018","unstructured":"INRS (2018b)\u00a0 [Patient care and chamber maintenance. Working safely with cytotoxic drugs]. INRS, Paris. https:\/\/www.inrs.fr\/. Accessed 15 Nov 2020"},{"key":"1706_CR24","volume-title":"INRS\u2014D\u00e9contamination en cas de renversement accidental. Travailler en s\u00e9curit\u00e9 avec les m\u00e9dicaments cytotoxiques","author":"INRS","year":"2018","unstructured":"INRS (2018c)\u00a0 [Decontamination in case of accidental spillage. Working safely with cytotoxic drugs]. INRS, Paris. https:\/\/www.inrs.fr\/. Accessed 15 Nov 2020"},{"key":"1706_CR27","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jpba.2018.03.024","volume":"154","author":"V Izzo","year":"2018","unstructured":"Izzo V, Charlier B, Bloise E et al (2018) A UHPLC-MS\/MS-based method for the simultaneous monitoring of eight antiblastic drugs in plasma and urine of exposed healthcare workers. J Pharm Biomed Anal 154:245\u2013251. https:\/\/doi.org\/10.1016\/j.jpba.2018.03.024","journal-title":"J Pharm Biomed Anal"},{"key":"1706_CR28","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1080\/15459624.2016.1237026","volume":"14","author":"T Kibby","year":"2017","unstructured":"Kibby T (2017) A review of surface wipe sampling compared to biologic monitoring for occupational exposure to antineoplastic drugs. J Occup Environ Hyg 14:159\u2013174. https:\/\/doi.org\/10.1080\/15459624.2016.1237026","journal-title":"J Occup Environ Hyg"},{"key":"1706_CR29","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.toxlet.2018.05.002","volume":"298","author":"M Koller","year":"2018","unstructured":"Koller M, B\u00f6hlandt A, Haberl C et al (2018) Environmental and biological monitoring on an oncology ward during a complete working week. Toxicol Lett 298:158\u2013163. https:\/\/doi.org\/10.1016\/j.toxlet.2018.05.002","journal-title":"Toxicol Lett"},{"key":"1706_CR30","first-page":"239","volume":"56","author":"R Law","year":"2010","unstructured":"Law R, Bozzo P, Koren G, Einarson A (2010) FDA pregnancy risk categories and the CPS. Can Fam Physician 56:239\u2013241","journal-title":"Can Fam Physician"},{"key":"1706_CR31","first-page":"153","volume-title":"Casarett & Doull\u2019s toxicology the basic science of poisons","author":"L Lehman-McKeenan","year":"2013","unstructured":"Lehman-McKeenan L (2013) Absorption, distribution, and excretion of toxicants. In: Klaassen CD (ed) Casarett & Doull\u2019s toxicology the basic science of poisons, 8th edn. Mc Graw Hill, New-York, pp 153\u2013183","edition":"8"},{"key":"1706_CR32","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.toxac.2018.01.001","volume":"29","author":"N Lepage","year":"2018","unstructured":"Lepage N, Canal-raffin M, Villa A (2018) Occupational exposure to antineoplastic drugs: informations for biological monitoring. Toxicol Anal Clin 29:387\u2013417. https:\/\/doi.org\/10.1016\/j.toxac.2018.01.001","journal-title":"Toxicol Anal Clin"},{"key":"1706_CR33","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1080\/00039896.1996.9936030","volume":"51","author":"RM Mader","year":"1996","unstructured":"Mader RM, Rizovski B, Steger GG et al (1996) Exposure of oncologic nurses to methotrexate in the treatment of osteosarcoma. Arch Environ Health 51:310\u2013314. https:\/\/doi.org\/10.1080\/00039896.1996.9936030","journal-title":"Arch Environ Health"},{"key":"1706_CR34","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jchromb.2017.06.028","volume":"1060","author":"PI Mathias","year":"2017","unstructured":"Mathias PI, Connor TH, B\u2019Hymer C (2017) A review of high performance liquid chromatographic-mass spectrometric urinary methods for anticancer drug exposure of health care workers. J Chromatogr B Analyt Technol Biomed Life Sci 1060:316\u2013324. https:\/\/doi.org\/10.1016\/j.jchromb.2017.06.028","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"1706_CR35","unstructured":"Matinet B, Rosankis E, L\u00e9onard M (2020)\u00a0[SUMER 2017 Survey. Exposures to occupational risks. Chemical products]. DARES.\u00a0https:\/\/dares.travail-emploi.gouv.fr\/enquetes. Accessed 15 Nov 2020"},{"key":"1706_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2020.09.003","author":"FL Nassan","year":"2020","unstructured":"Nassan FL, Chavarro JE, Johnson CY et al (2020) Pre-pregnancy handling of antineoplastic drugs and risk of miscarriage in female nurses. Ann Epidemiol. https:\/\/doi.org\/10.1016\/j.annepidem.2020.09.003","journal-title":"Ann Epidemiol"},{"key":"1706_CR37","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1016\/j.jchromb.2010.02.011","volume":"878","author":"S Ndaw","year":"2010","unstructured":"Ndaw S, Denis F, Marsan P et al (2010) Biological monitoring of occupational exposure to 5-fluorouracil: urinary \u03b1-fluoro-\u03b2-alanine assay by high performance liquid chromatography tandem mass spectrometry in health care personnel. J Chromatogr B Anal Technol Biomed Life Sci 878:2630\u20132634. https:\/\/doi.org\/10.1016\/j.jchromb.2010.02.011","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci"},{"key":"1706_CR38","unstructured":"Ndaw S, Denis F, Marsan P et al (2018)\u00a0[Occupational exposure of hospital health personnel to cytotoxic drugs. Biometrology and measurement of surface contamination]. INRS. R\u00e9f\u00e9rences en sant\u00e9 au travail\u2014TF 255 N\u00b0154:81\u201392. https:\/\/www.inrs.fr\/.  Accessed 15 Nov 2020\u00a0"},{"key":"1706_CR39","doi-asserted-by":"publisher","first-page":"852","DOI":"10.2105\/ajph.84.5.852","volume":"84","author":"MA Newman","year":"1994","unstructured":"Newman MA, Valanis BG, Schoeny RS, Hee SQ (1994) Urinary biological monitoring markers of anticancer drug exposure in oncology nurses. Am J Public Health 84:852\u2013855. https:\/\/doi.org\/10.2105\/ajph.84.5.852","journal-title":"Am J Public Health"},{"key":"1706_CR40","volume-title":"NIOSH list of antineoplastic and other hazardous drugs in healthcare settings, centers for disease control and prevention","author":"NIOSH","year":"2016","unstructured":"NIOSH (2016) NIOSH list of antineoplastic and other hazardous drugs in healthcare settings, centers for disease control and prevention. NIOSH, Washington, DC. https:\/\/www.cdc.gov\/niosh\/topics\/hazdrug\/default.html. Accessed 15 Nov 2020"},{"key":"1706_CR41","first-page":"351","volume":"29","author":"C Nisse","year":"2017","unstructured":"Nisse C, Barbeau D, Brunet D et al (2017) Practice guidelines for biological monitoring of occupational exposure (BMOE) to chemicals: Recommendations of the French Society of Occupational Medicine, associated with the French Society of Analytical Toxicology and the Society of Clinical Toxicology. ToxAc 29:351\u2013376","journal-title":"ToxAc"},{"key":"1706_CR42","first-page":"195","volume":"24","author":"P Odraska","year":"2011","unstructured":"Odraska P, Mazurova E, Dolezalova L, Blaha L (2011) In vitro evaluation of the permeation of cytotoxic drugs through reconstructed human epidermis and oral epithelium. Klin Onkol 24:195\u2013202","journal-title":"Klin Onkol"},{"key":"1706_CR43","first-page":"376","volume":"69","author":"C Poupeau","year":"2016","unstructured":"Poupeau C, Roland C, Bussi\u00e8res JF (2016) Surveillance urinaire des professionnels de la sant\u00e9 expos\u00e9s aux antin\u00e9oplasiques dans le cadre de leur travail: revue de la litt\u00e9rature de 2010 \u00e0 2015. Can J Hosp Pharm 69:376\u2013387","journal-title":"Can J Hosp Pharm"},{"key":"1706_CR44","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1177\/1078155216643860","volume":"23","author":"C Poupeau","year":"2017","unstructured":"Poupeau C, Tanguay C, Plante C et al (2017) Pilot study of biological monitoring of four antineoplastic drugs among Canadian healthcare workers. J Oncol Pharm Pract 23:323\u2013332. https:\/\/doi.org\/10.1177\/1078155216643860","journal-title":"J Oncol Pharm Pract"},{"key":"1706_CR45","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1472-6955-9-15","volume":"9","author":"PA Ratner","year":"2010","unstructured":"Ratner PA, Spinelli JJ, Beking K et al (2010) Cancer incidence and adverse pregnancy outcome in registered nurses potentially exposed to antineoplastic drugs. BMC Nurs 9:15. https:\/\/doi.org\/10.1186\/1472-6955-9-15","journal-title":"BMC Nurs"},{"key":"1706_CR46","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/BF00381477","volume":"64","author":"PJ Sessink","year":"1992","unstructured":"Sessink PJ, Boer KA, Scheefhals AP et al (1992) Occupational exposure to antineoplastic agents at several departments in a hospital. Environmental contamination and excretion of cyclophosphamide and ifosfamide in urine of exposed workers. Int Arch Occup Environ Health 64:105\u2013112. https:\/\/doi.org\/10.1007\/BF00381477","journal-title":"Int Arch Occup Environ Health"},{"key":"1706_CR47","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/00039896.1994.9940377","volume":"49","author":"PJ Sessink","year":"1994","unstructured":"Sessink PJ, Van de Kerkhof MC, Anzion RB et al (1994) Environmental contamination and assessment of exposure to antineoplastic agents by determination of cyclophosphamide in urine of exposed pharmacy technicians: is skin absorption an important exposure route? Arch Environ Health 49:165\u2013169. https:\/\/doi.org\/10.1080\/00039896.1994.9940377","journal-title":"Arch Environ Health"},{"key":"1706_CR48","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1136\/oem.49.12.855","volume":"49","author":"T Skov","year":"1992","unstructured":"Skov T, Maarup B, Olsen J et al (1992) Leukaemia and reproductive outcome among nurses handling antineoplastic drugs. Br J Ind Med 49:855\u2013861. https:\/\/doi.org\/10.1136\/oem.49.12.855","journal-title":"Br J Ind Med"},{"key":"1706_CR49","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1177\/1078155209358632","volume":"17","author":"S Sugiura","year":"2011","unstructured":"Sugiura S, Asano M, Kinoshita K et al (2011) Risks to health professionals from hazardous drugs in Japan: a pilot study of environmental and biological monitoring of occupational exposure to cyclophosphamide. J Oncol Pharm Pract 17:14\u201319. https:\/\/doi.org\/10.1177\/1078155209358632","journal-title":"J Oncol Pharm Pract"},{"key":"1706_CR50","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1177\/1078155210381931","volume":"17","author":"R Turci","year":"2011","unstructured":"Turci R, Minoia C, Sottani C et al (2011) Occupational exposure to antineoplastic drugs in seven Italian hospitals: the effect of quality assurance and adherence to guidelines. J Oncol Pharm Pract 17:320\u2013332. https:\/\/doi.org\/10.1177\/1078155210381931","journal-title":"J Oncol Pharm Pract"},{"key":"1706_CR51","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.toxlet.2019.08.022","volume":"316","author":"CL Ursini","year":"2019","unstructured":"Ursini CL, Omodeo Sal\u00e8 E, Fresegna AM et al (2019) Antineoplastic drug occupational exposure: a new integrated approach to evaluate exposure and early genotoxic and cytotoxic effects by no-invasive Buccal Micronucleus Cytome Assay biomarker. Toxicol Lett 316:20\u201326. https:\/\/doi.org\/10.1016\/j.toxlet.2019.08.022","journal-title":"Toxicol Lett"},{"key":"1706_CR52","doi-asserted-by":"publisher","first-page":"28","DOI":"10.2486\/indhealth.2014-0025","volume":"53","author":"AF Villa","year":"2015","unstructured":"Villa AF, El Balkhi S, Aboura R et al (2015) Evaluation of oxaliplatin exposure of healthcare workers during heated intraperitoneal perioperative chemotherapy (HIPEC). Ind Health 53:28\u201337. https:\/\/doi.org\/10.2486\/indhealth.2014-0025","journal-title":"Ind Health"},{"key":"1706_CR53","doi-asserted-by":"publisher","first-page":"e033040","DOI":"10.1136\/bmjopen-2019-033040","volume":"9","author":"A Villa","year":"2019","unstructured":"Villa A, Molimard M, Bignon E et al (2019) Study protocol for the assessment of nurses internal contamination by antineoplastic drugs in hospital centres: a cross-sectional multicentre descriptive study. BMJ Open 9:e033040. https:\/\/doi.org\/10.1136\/bmjopen-2019-033040","journal-title":"BMJ Open"},{"key":"1706_CR54","doi-asserted-by":"publisher","first-page":"122305","DOI":"10.1016\/j.jchromb.2020.122305","volume":"1156","author":"A Villa","year":"2020","unstructured":"Villa A, Tremolet K, Martinez B et al (2020) A highly sensitive UHPLC-MS\/MS method for urine biological monitoring of occupational exposure to anthracycline antineoplastic drugs and routine application. J Chromatogr B Analyt Technol Biomed Life Sci 1156:122305. https:\/\/doi.org\/10.1016\/j.jchromb.2020.122305","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"1706_CR55","volume-title":"Biological monitoring of chemical exposure in the workplace\u2014guidelines","author":"WHO","year":"1996","unstructured":"WHO (1996) Biological monitoring of chemical exposure in the workplace\u2014guidelines , vol 1. World Health Organization, Geneva"},{"key":"1706_CR56","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1093\/annhyg\/mes061","volume":"57","author":"J Yoshida","year":"2013","unstructured":"Yoshida J, Koda S, Nishida S et al (2013) Association between occupational exposure and control measures for antineoplastic drugs in a pharmacy of a hospital. Ann Occup Hyg 57:251\u2013260. https:\/\/doi.org\/10.1093\/annhyg\/mes061","journal-title":"Ann Occup Hyg"},{"key":"1706_CR57","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/ajim.22553","volume":"59","author":"X Zhang","year":"2016","unstructured":"Zhang X, Zheng Q, Lv Y et al (2016) Evaluation of adverse health risks associated with antineoplastic drug exposure in nurses at two Chinese hospitals: the effects of implementing a pharmacy intravenous admixture service. Am J Ind Med 59:264\u2013273. https:\/\/doi.org\/10.1002\/ajim.22553","journal-title":"Am J Ind Med"}],"container-title":["International Archives of Occupational and Environmental Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00420-021-01706-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00420-021-01706-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00420-021-01706-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T04:30:32Z","timestamp":1633408232000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00420-021-01706-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,22]]},"references-count":57,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["1706"],"URL":"https:\/\/doi.org\/10.1007\/s00420-021-01706-x","relation":{},"ISSN":["0340-0131","1432-1246"],"issn-type":[{"value":"0340-0131","type":"print"},{"value":"1432-1246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,22]]},"assertion":[{"value":"17 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Following the opinion of the French Regional Ethics Committee for the Protection of Persons (CPP n\u00b0 2014\/87), this study is considered to be outside the scope of the provisions governing biomedical research and routine care.The study was conducted in accordance with the relevant national legislation for observational studies. The study was obtained the approvals from the National advisory committee on medical research information (CCTIRS) and the French data protection agency (CNIL). This study was registered in the EUPAS registry, as EUPAS19729 (). This study is registered on the ClinicalTrials.gov website, under the number NCT03137641.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All nurses provided a written informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The participants gave consent to their data being published in the journal.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}